SureTrader
Home > Boards > US Listed > Biotechs >

BG Medicine, Inc. (BGMD)

BGMD RSS Feed 		Add BGMD Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 4/18/2018 10:07:38 AM - Followers: 43 - Board type: Free - Posts Today: 0


Welcome to BG Medicine Inc. (BGMD) Board!!






BG Medicine, Inc. is dedicated to developing and delivering innovative solutions for healthcare providers that

provide insight and transform the clinical care of heart failure and related disorders.


galectin-3 mechanism of action videohttp://www.bg-medicine.com/wp-content/uploads/2014/11/BGM_role-of-galectin-3.mp4?id=0


 

LEADERSHIP

Paul R. Sohmer, M.D. / President and CEOPaul R. Sohmer, M.D. joined BG Medicine in May of 2013 as President, CEO and member of the board of directors. Dr. Sohmer served as President and Chief Executive Officer of Viracor-IBT Laboratories, Inc., a diagnostic and research laboratory specializing in allergy, immunology, and infectious disease testing from January 2011 to September of 2012. Prior to joining Viracor-IBT Laboratories, from February 2009 to January 2011, Dr. Sohmer served as Chief Executive Officer of Orthocon, Inc., a company that develops, manufactures, markets, and sells implantable products designed to stop bone bleeding. From 2007 to 2009, Dr. Sohmer served on the RadPharm, Inc. board of directors, and from 2008 to 2009, he served as chairman of the board of directors of Molecular Biometrics, Inc. Dr. Sohmer served as Interim CEO of Cylex, Inc. from January through March of 2008 and CEO of Pathway Diagnostics from May to September of 2008. From June 2000 to December 2006, Dr. Sohmer served as Chairman, President and Chief Executive Officer of TriPath Imaging, Inc. (NASDAQ:TPTH). From 1997 to 2000, Dr. Sohmer served as President and Chief Executive Officer of Neuromedical Systems, Inc. (NASDAQ:NSIX). From 1992 to 1996, Dr. Sohmer served as President and Chief Executive Officer of Genetrix, Inc., a genetic testing lab. From 1991-1992, Dr. Sohmer served as Vice President of Professional Services for Nichols Institute. From 1985 to 1991, Dr. Sohmer served as President and Chief Executive Officer of Pathology Institute, Inc., where he led the first commercial introduction of polymerase chain reaction (PCR) for diagnosis of HIV and founded the Chiron Reference Laboratory. Dr. Sohmer received his B.A. from Northwestern University and M.D. from the Chicago Medical School. Dr. Sohmer was named the Ernst and Young Carolinas Life Sciences Entrepreneur of the Year in 2005.

Stephen Hall / Executive Vice President, Chief Financial Office
Mr. Hall joined BG Medicine from Stemline Therapeutics, Inc., a publicly traded clinical stage biopharmaceutical company, where he held the position of Vice President Finance, Treasurer, Principal Financial and Chief Accounting Officer and assisted in financings in excess of $100m. Prior to Stemline, Mr. Hall served as Chief Financial Officer at both life science and medical device companies, including Orthocon, Inc., Helicos BioSciences Corporation, TriPath Imaging, Inc., and Colorado MEDtech, Inc. Mr. Hall, a certified public accountant, began his professional career with Peat, Marwick, Mitchell & Co., in Chicago, IL. In addition to his experience as an operating CFO, he spent nearly 10 years in commercial banking. He received his AB degree from Harvard College and MBA from Stanford University Graduate School of Business.

Aram Adourian, Ph.D. / Senior Vice President and Chief Scientific Officer
Dr. Adourian joined BG Medicine from the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. While at MIT, he served as Project Manager for Bioinformatics specializing in the development of novel systems and approaches for biomolecular sequencing, analysis and modeling. Dr. Adourian earned his Ph.D. at Harvard University in Statistical Physics, where he was a recipient of the Rudenberg Research Prize, and received his undergraduate degree in Physics from Cornell University.

Raul Diaz / Vice President, Operations and Information Technologies
Mr. Diaz joined BG Medicine from Newcogen Group Inc.  While at Newcogen Group, he served as Director of Information Technologies where he was responsible for all aspects of the organization’s information technology infrastructure.  Prior to Newcogen, Mr. Diaz spent years as a consultant specializing in information technology architecture, compliance, knowledge management and business continuity.  Mr. Diaz received a Bachelor’s degree in Electrical Engineering from the University of Massachusetts Lowell.

Headquarters

BG Medicine, Inc.                       
880 Winter Street
Suite 210
Waltham, MA 02451
+ 1 (781) 890.1199
http://www.bg-medicine.com/
communications@bg-medicine.com



 
 

 
SureTrader
BGMD
Current Price
Volume:
Bid Ask Day's Range
BGMD Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1777  Sticky Note $BGMD recent news/filings mick 01/18/16 03:27:33 PM
#1912   FDA has recently approved the GORE® CARDIOFORM Septal foreontee 04/18/18 10:07:37 AM
#1911   http://www.stockscores.com/charts/charts/?ticker=BGMD mick 04/07/18 11:04:46 AM
#1910   I think that management has decided that this ToldYaSo 02/23/18 09:26:53 AM
#1909   http://www.barchart.com/detailedquote/stocks/BGMD mick 02/22/18 09:15:33 PM
#1908   (BGMD) 0.38 ? 0.0 (0.00%) mick 01/23/18 07:01:41 PM
#1907   new patent application 12/28/2017 anon352630 01/09/18 09:04:49 PM
#1906   Holy blank Batman. I had to rub my kcbigbucks 12/14/17 04:40:27 PM
#1905   The 2016 annual meeting of stockholders (August 5, max0001 12/09/17 01:05:02 AM
#1904   There was a shareholders meeting? kcbigbucks 12/08/17 11:30:19 PM
#1903   Any news from shareholders meeting? max0001 12/08/17 08:26:34 AM
#1902   Galectin-3 test under development in ADVIA Centaur max0001 12/08/17 08:23:08 AM
#1901   BG Medicine and Siemens Healthcare Diagnostics (Galectin-3 test)? max0001 12/07/17 05:31:57 AM
#1900   Galectin-3 test-Architect i 2000srAbbott and VIDAS® bioMerieux. max0001 12/07/17 05:17:47 AM
#1899   http://onlinelibrary.wiley.com/doi/10.1002/rth2.12038/full max0001 12/07/17 12:46:01 AM
#1898   http://www.barchart.com/snapopinion/stocks/BGMD mick 12/01/17 05:48:48 AM
#1897   Who is buying? It sure would be nice kcbigbucks 11/29/17 01:06:18 AM
#1896   READING/ THANK YOU/ http://www.otcmarkets.com/stock/BGMD/quote mick 11/25/17 12:59:43 PM
#1895   Thank you? For what? Did I miss something? kcbigbucks 11/20/17 10:13:51 PM
#1894   THANK YOU $BGMD mick 11/20/17 12:13:46 PM
#1893   Sooooo.... Put the chart on 3 year. A tste9 11/20/17 10:50:39 AM
#1892   Does BGMD still exist? kcbigbucks 11/08/17 01:38:41 PM
#1891   https://www.stockscores.com/charts/charts/?ticker=BGMD mick 10/08/17 01:09:06 PM
#1890   Bg Medicine, Inc. (P (BGMD) mick 08/26/17 01:49:50 PM
#1889   I wish they would kill it or come kcbigbucks 07/10/17 11:00:40 PM
#1888   Is the company alive on life support, or ROCKHard 07/10/17 09:14:34 PM
#1887   Bg Medicine, Inc. (P (BGMD) mick 07/09/17 09:55:55 AM
#1886   Bg Medicine, Inc. (P (BGMD) mick 05/14/17 09:13:10 AM
#1885   its a pos company full of liars that foreontee 04/27/17 06:17:06 AM
#1884   Bg Medicine, Inc. (P (BGMD) mick 04/08/17 11:26:41 AM
#1883   Is this a new company selling Gal 3 kcbigbucks 03/24/17 11:51:39 AM
#1882   Bg Medicine, Inc. (P (BGMD) mick 03/22/17 01:34:12 PM
#1881   Thought this would be viable. Boy did they ROCKHard 03/17/17 07:02:02 PM
#1880   https://www.ncbi.nlm.nih.gov/gene/3958 kcbigbucks 02/25/17 12:37:36 PM
#1879   Great article http://www.townsendletter.com/Jan2017/galectin30117_2.html kcbigbucks 02/14/17 03:45:46 PM
#1878   Bg Medicine, Inc. (P (BGMD) mick 02/11/17 03:47:00 PM
#1877   Holy blank Batman I had to take a kcbigbucks 01/19/17 12:59:06 PM
#1876   Gal-3 Predicts 60 day Re-admission in Heart Failure 1/16/17 http://www.doctorsl BlueRayn 01/17/17 12:45:12 AM
#1875   Bg Medicine, Inc. (P (BGMD) mick 12/26/16 11:43:23 PM
#1874   If it gets below $.01 I will buy TClap 12/21/16 05:28:16 PM
#1873   Pretty high volume and to be honest surprised kcbigbucks 12/19/16 12:58:29 PM
#1872   I think they are beginning to dilute. Share dheminger 12/19/16 09:24:40 AM
#1871   People still here? Insane that they are still michelinvests 12/19/16 08:48:02 AM
#1870   Bg Medicine, Inc. (P (BGMD) mick 12/04/16 09:54:35 PM
#1869   BGMD News: Initial Statement of Beneficial Ownership (3) 06/27/2016 mick 12/04/16 09:54:16 PM
#1868   Actually they should have been zero cash since dheminger 11/15/16 10:22:09 AM
#1867   So zero cash? learning curve 11/14/16 11:10:05 PM
#1866   No problem we are in this together. dheminger 11/14/16 08:15:40 PM
#1865   Thanks for replying :-) kcbigbucks 11/14/16 07:26:58 PM
#1864   I figured it probably wasn't worth registering for kcbigbucks 11/14/16 07:26:35 PM
#1863   It was just a filing explaining the TOS dheminger 11/14/16 07:24:18 PM
PostSubject
© 2018 InvestorsHub.com, Inc.